维普中文期刊产品整合服务
6篇 您的检索式:作者名="Wohlwend L"
    题名 作者 年代 出处 被引量
1Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents results of the sirolimus-eluting versus paclitaxel-eluting stents for coronary revascularization LATE Trial显示文摘R(a)ber L Wohlwend L Wigger M 2011Circulation2011,123,24:1
2Five-year clinical and angiographic outcomes of a randomized comparison of sirolimuseluting and paclitaxel-eluting stents:results of the sirolimus-eluting versus paclitaxel-eluting stents for coronary rewascularization late trial显示文摘Raber L Wohlwend L Wigger M 2011Circulation2011,123,24:1
3Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus- eluting and paclitaxel-eluting stents: results of the Sirolimus- Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascu- larization LATE trial显示文摘Raber L Wohlwend L Wigger M 2011Circulation2011,123,24:1
4Cell surface antigen CD5 is a marker for activated human B cells显示文摘Werner-Favre C Vischer T L Wohlwend D 1989Eur J Immunol1989,19,7:1
5Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-elu-ting and paclitaxel-eluting stents results of the sirolimus-eluting versus paclitaxel-eluting stents for coronary revascularization LATE trial显示文摘Raeber L Wohlwend L Wigger M 0,,24:1
6Five - year clinical and angiographie outcomes of a randomized com- parison of sirolimus - eluting and paclitaxel - eluting stents: results of the sirolimus - eluting versus paclitaxel - eluting stents for coronary revaseulariza tion LATE trial 显示文摘Raber L Wohlwend L Wigger M 2011Circulation2011,123,24:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费